aXichem ABFRA:A6X -1.88%61 Current Ratio is 4.24 as of Mar. 2026, which is 22% below its 10-year median of 5.46. GuruFocus rates FRA:A6X with a GF Score™ of 61/100 and a GF Value™ of €0.26. Among 1,604 Chemicals companies, aXichem AB ranks better than 82.67% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. aXichem AB's current ratio for the quarter that ended in Mar. 2026 was 4.24.
aXichem AB has a current ratio of 4.24. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for aXichem AB's Current Ratio or its related term are showing as below:
FRA:A6X'
s Current Ratio Range Over the Past 10 Years
Min: 0.43 Med: 5.46 Max: 29.16
Current: 4.23
During the past 13 years, aXichem AB's highest Current Ratio was 29.16. The lowest was 0.43. And the median was 5.46.
FRA:A6X's Current Ratio is ranked better than 82.67% of 1604
companies
in the Chemicals industry
Industry Median: 1.89
vs FRA:A6X: 4.23
aXichem AB (FRA:A6X) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
aXichem AB Current Ratio Related Terms
aXichem AB Current Ratio Historical Data
* Premium members only.
The historical data trend for aXichem AB's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:A6X vs LIN, SHW, ECL: Current Ratio Comparison
For the Specialty Chemicals subindustry, aXichem AB's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
aXichem AB Current Ratio vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, aXichem AB's Current Ratio distribution charts can be found below:
* The bar in red indicates where aXichem AB's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
aXichem AB (FRA:A6X) has a Current Ratio of 4.24 as of Mar. 2026. This is 22% below median its historical median of 5.46. Over the past decade, aXichem AB's Current Ratio has ranged from 0.43 to 29.16. According to the industry distribution chart, aXichem AB ranks #278 out of 1604 companies in the Chemicals industry, placing it in the top 17.3%.
Is aXichem AB's Current Ratio too high?
aXichem AB's current Current Ratio of 4.24 is 22% below median its 10-year median of 5.46. Over the past 10 years, this metric has ranged from a low of 0.43 to a high of 29.16. The Chemicals industry median Current Ratio is 1.89. aXichem AB's value of 4.24 is 124.3% above this industry median. Based on the distribution chart, aXichem AB ranks #278 out of 1604 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, aXichem AB has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does aXichem AB's Current Ratio compare to LIN and SHW?
According to the Chemicals industry distribution chart, aXichem AB ranks #278 out of 1604 companies for Current Ratio. This places aXichem AB in the top 17% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.89. aXichem AB's value of 4.24 is 124.3% above this benchmark. Historically, aXichem AB's own Current Ratio has ranged from 0.43 to 29.16 over the past decade. While the company's 10-year median is 5.46 vs. the industry median of 1.89, aXichem AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Chemicals company?
The median Current Ratio among Chemicals companies is 1.89, based on 1,604 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. aXichem AB's current Current Ratio of 4.24 is 124.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Chemicals industry, the median Current Ratio is 1.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. aXichem AB's current Current Ratio is 4.24, which is 22% below median its own 10-year median of 5.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is aXichem AB stock overvalued right now?
aXichem AB (FRA:A6X) has a current Current Ratio of 4.24. The stock's GF Value™ is €0.26, compared to a current price of €0.16 — trading 39.8% below its estimated fair value. The current Current Ratio is 4.24, which is 22% below median its 10-year median of 5.46 and 124.3% above the Chemicals industry median of 1.89. aXichem AB's overall GF Score™ is 61/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For aXichem AB (FRA:A6X), the current Current Ratio is 4.24 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is aXichem AB (FRA:A6X) Overvalued in 2026?
Based on GuruFocus' analysis, aXichem AB stock appears to be undervalued.
The current stock price of €0.16 is trading 39.8% below its estimated GF Value™ of €0.26.
Key valuation signals for FRA:A6X:
Current Ratio: 4.24 (22% below median its 10-year median of 5.46)
GF Value™: €0.26 vs. price of €0.16 (39.8% below fair value)
Industry Position: 124.3% above the Chemicals median (#278 of 1604)
No single metric tells the full story. See the FRA:A6X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
aXichem AB develops, patents, markets and sells natural analogue industrial chemicals, which are synthetically produced substances with similar and comparable properties to natural substances. The Company's business concept is to develop, patent, market and sell natural analogue industrial chemicals. Its commercial focus is on the proprietary patented product phenylcapsaicin, the Company's first product, which is marketed under the registered trademarks aXiphen as an additive in animal feed and aXivite as an ingredient in food supplements and as a bioenhancer. The Company's product portfolio comprises Phenylcapsaicin, aXiphen, aXiphen bio, and aXivite. The Company's focus is on establishing aXiphen as an additive in poultry feed and pig feed.
61GF Score
Get the complete analysis for FRA:A6X
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:A6X has been successfully added to your 
